Ipamorelin
Selective growth hormone releasing peptide with minimal side effects
🛑 WADA Banned 18 views
🛑 WADA BANNED - Prohibited in competitive sports as selective growth hormone releasing peptide
Overview
Ipamorelin is a growth hormone-releasing peptide (GHRP) that tells your pituitary gland to produce more growth hormone. It's considered one of the "cleanest" options in its class because it specifically targets growth hormone without significantly affecting other hormones. **Why choose Ipamorelin?** Unlike other growth hormone peptides that can spike cortisol (stress hormone) or increase appetite dramatically, Ipamorelin is highly selective. It gives you the growth hormone boost without as many unwanted side effects. **What the research shows:** • Stimulates natural, pulsatile growth hormone release • Minimal impact on cortisol, prolactin, or appetite • May support lean muscle development and fat loss • Could improve sleep quality and recovery • Often combined with CJC-1295 for enhanced effects **How it works:** Ipamorelin mimics ghrelin (the "hunger hormone") but is much more selective. It binds to growth hormone secretagogue receptors in your pituitary, triggering GH release in a pattern similar to your body's natural rhythms. **Typical use:** Injected subcutaneously, often 2-3 times daily or before bed to enhance natural nighttime GH pulses. **Important to know:** Ipamorelin is banned by WADA and not FDA-approved. While research is promising, large-scale human clinical trials are limited. --- **Sources:** Raun K, et al. (1998) European Journal of Endocrinology | Anderson LL, et al. (2009) Journal of Pharmacology and Experimental Therapeutics

Quick Facts
Formula:C38H49N9O5
Molecular Weight:711.85
Sequence:Aib-His-D-2Nal-D-Phe-Lys-NH2
Mechanism:Selective GH secretagogue with minimal side effects
⚠️ Safety Information
Research compound only. Forbidden in sport. May cause temporary flushing, mild head pressure, or minor water retention.
Research Citations
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.
Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H (1999)
Ipamorelin, the first selective growth hormone secretagogue.
Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH (1998)
+ 22 more citations